Browse the latest research summaries in the field of biomedical for spinal cord injury patients and caregivers.
Showing 661-670 of 904 results
Frontiers in Pharmacology, 2024 • August 13, 2024
The study introduces Mn-doped ZIF nanozymes as a novel approach to tumor therapy. These nanozymes leverage the high H2O2 concentration in tumor microenvironments to generate hydroxyl radicals, directl...
KEY FINDING: Mn-ZIF nanozymes possess peroxidase (POD) activity, enabling them to oxidize tumor-localized H2O2 into hydroxyl radicals (·OH), effectively killing tumor cells.
Journal of Nanobiotechnology, 2024 • August 12, 2024
This study investigated the therapeutic potential of intranasal administration of mesenchymal stem cell-derived small extracellular vesicles (sEVs) in treating amyotrophic lateral sclerosis (ALS) usin...
KEY FINDING: Intranasally-delivered sEVs entered the central nervous system and were extensively taken up by spinal neurons and some microglia.
Smart Medicine, 2023 • January 1, 2023
This study introduces bFGF‐loaded GelMA microspheres with excellent biocompatibility and sustained drug release for spinal cord injury repair. The microspheres are prepared using microfluidic technolo...
KEY FINDING: bFGF-loaded GelMA microspheres significantly promoted the proliferation and differentiation of neural stem cells in vitro.
Smart Medicine, 2022 • October 20, 2022
This review summarizes recent advances in cell engineering, tissue engineering, and combined therapies for spinal cord injury (SCI) treatment. It covers cell-based strategies with neuroprotective and ...
KEY FINDING: Recent advances in bioengineering have shown that therapies based on cells, biomaterials, and biomolecules are effective in spinal cord regeneration.
Adv Pharm Bull, 2024 • March 10, 2024
Spinal cord injury (SCI) is an important factor in sensory and motor disorders that affects thousands of people every year. In the last decade, the use of 3D printed scaffolds in the treatment of SCI ...
KEY FINDING: 3D-C/C scaffold implantation leads to improving the locomotor function in SCI rat.
Materials Today Bio, 2024 • June 3, 2024
This study introduces a novel magnetically responsive injectable hydrogel composed of gellan gum, hyaluronic acid, collagen, and magnetic nanoparticles (MNPs) for aligned tissue regeneration. The hydr...
KEY FINDING: The hydrogel exhibits mechanical properties comparable to human soft tissues, such as skeletal muscle, suggesting its suitability for tissue engineering applications.
Tissue Eng Regen Med, 2024 • August 31, 2024
The study aimed to identify the early events associated with enhanced skin regeneration in a fetal sheep full thickness wound model using collagen scaffolds functionalized with heparin, fibroblast grow...
KEY FINDING: COL-HEP/GF scaffolds induce a tight but subtle control over cell signaling and extracellular matrix organization.
Int. J. Mol. Sci., 2024 • September 4, 2024
3D bioprinting shows promise in SCI repair by creating scaffolds that mimic the native spinal cord architecture, utilizing bioinks and stem cells. Innovative strategies improve electrical conductivity...
KEY FINDING: 3D bioprinting enables the precise creation of scaffolds mimicking the spinal cord's structure, with the ability to embed living cells directly, promoting their survival and integration.
Materials Today Bio, 2024 • September 14, 2024
This study developed an injectable adhesive Exo-dECM hydrogel comprising a decellularized extracellular matrix and exosomes derived from cortical neurons as a potential therapeutic intervention for SC...
KEY FINDING: The Exo-dECM hydrogel exhibited robust mechanical stability and excellent cytocompatibility, allowing effective injection into the injury site to fill the lesion cavity.
Journal of Nanobiotechnology, 2024 • August 22, 2024
This study investigates the role of spinal cord-derived microvascular endothelial cells (SCMECs) in promoting axon growth after spinal cord injury (SCI). The researchers found that SCMECs promote axon...
KEY FINDING: SCMECs promote axon outgrowth in a non-contact fashion by downregulating miR-323-5p expression in neurons.